Jiaxin Zhou, Jianping Hu, Na Tian, Yingying Zhang, Chunshuang Shang
{"title":"Neurotoxic mechanisms of the pesticide myclobutanil: integration of network toxicology, transcriptomics, and molecular simulation.","authors":"Jiaxin Zhou, Jianping Hu, Na Tian, Yingying Zhang, Chunshuang Shang","doi":"10.1080/00498254.2025.2550363","DOIUrl":null,"url":null,"abstract":"<p><p>Myclobutanil, a pesticide commonly employed in agricultural practices for fruits, vegetables, and crops, is capable of crossing the blood-brain barrier (BBB) and persisting in cerebrospinal fluid, posing significant risks to human health. Consequently, it is crucial to systematically explore the molecular toxicological mechanisms underlying its neurotoxic effects.This study employed a systems-level approach that integrated weighted gene co-expression network analysis (WGCNA) and protein-protein interaction (PPI) network construction, followed by molecular docking and molecular dynamics (MD) simulations for validation.A total of 75 key targets were identified using cheminformatics tools (SEA, SwissTargetPrediction, TargetNet) and disease databases (GeneCards, OMIM, DisGeNET). Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway analysis revealed that Myclobutanil exposure induces neurotoxicity through multiple signalling pathways, particularly the Pathways of neurodegeneration-multiple diseases and PI3K-Akt signalling pathway.Transcriptomic analysis and WGCNA identified RAF1 as a significantly correlated target with Myclobutanil exposure. Molecular docking and MD simulations further confirmed a strong binding affinity between RAF1 and Myclobutanil, suggesting that RAF1 plays a pivotal role in Myclobutanil exposure neurotoxicity.This prospective study yields predictive insight into the molecular events underlying Myclobutanil exposure neurotoxicity and highlights candidate therapeutic targets that remain to be validated <i>in vivo</i>.</p>","PeriodicalId":23812,"journal":{"name":"Xenobiotica","volume":" ","pages":"572-585"},"PeriodicalIF":1.2000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Xenobiotica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00498254.2025.2550363","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/4 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Myclobutanil, a pesticide commonly employed in agricultural practices for fruits, vegetables, and crops, is capable of crossing the blood-brain barrier (BBB) and persisting in cerebrospinal fluid, posing significant risks to human health. Consequently, it is crucial to systematically explore the molecular toxicological mechanisms underlying its neurotoxic effects.This study employed a systems-level approach that integrated weighted gene co-expression network analysis (WGCNA) and protein-protein interaction (PPI) network construction, followed by molecular docking and molecular dynamics (MD) simulations for validation.A total of 75 key targets were identified using cheminformatics tools (SEA, SwissTargetPrediction, TargetNet) and disease databases (GeneCards, OMIM, DisGeNET). Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway analysis revealed that Myclobutanil exposure induces neurotoxicity through multiple signalling pathways, particularly the Pathways of neurodegeneration-multiple diseases and PI3K-Akt signalling pathway.Transcriptomic analysis and WGCNA identified RAF1 as a significantly correlated target with Myclobutanil exposure. Molecular docking and MD simulations further confirmed a strong binding affinity between RAF1 and Myclobutanil, suggesting that RAF1 plays a pivotal role in Myclobutanil exposure neurotoxicity.This prospective study yields predictive insight into the molecular events underlying Myclobutanil exposure neurotoxicity and highlights candidate therapeutic targets that remain to be validated in vivo.
期刊介绍:
Xenobiotica covers seven main areas, including:General Xenobiochemistry, including in vitro studies concerned with the metabolism, disposition and excretion of drugs, and other xenobiotics, as well as the structure, function and regulation of associated enzymesClinical Pharmacokinetics and Metabolism, covering the pharmacokinetics and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in manAnimal Pharmacokinetics and Metabolism, covering the pharmacokinetics, and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in animalsPharmacogenetics, defined as the identification and functional characterisation of polymorphic genes that encode xenobiotic metabolising enzymes and transporters that may result in altered enzymatic, cellular and clinical responses to xenobioticsMolecular Toxicology, concerning the mechanisms of toxicity and the study of toxicology of xenobiotics at the molecular levelXenobiotic Transporters, concerned with all aspects of the carrier proteins involved in the movement of xenobiotics into and out of cells, and their impact on pharmacokinetic behaviour in animals and manTopics in Xenobiochemistry, in the form of reviews and commentaries are primarily intended to be a critical analysis of the issue, wherein the author offers opinions on the relevance of data or of a particular experimental approach or methodology